$116 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 112 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XGN | New | EXAGEN INC | $1,355,000 | – | 87,450 | +100.0% | 1.17% | – |
| AVGR | New | AVINGER INC | $660,000 | – | 794,768 | +100.0% | 0.57% | – |
| CSTL | New | CASTLE BIOSCIENCES INC | $505,000 | – | 27,920 | +100.0% | 0.44% | – |
| ATEC | New | ALPHATEC HOLDINGS INC | $432,000 | – | 86,000 | +100.0% | 0.37% | – |
| NXPI | New | NXP SEMICONDUCTORS N V | $278,000 | – | 2,550 | +100.0% | 0.24% | – |
| BIOS | New | OPTION CARE HEALTH INC | $259,000 | – | 81,000 | +100.0% | 0.22% | – |
| VRML | New | VERMILLION INC | $176,000 | – | 336,000 | +100.0% | 0.15% | – |
| New | OBALON THERAPEUTICS INC | $58,000 | – | 30,000 | +100.0% | 0.05% | – | |
| ATHX | New | ATHERSYS INC | $19,000 | – | 14,000 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-10-23
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEOGENOMICS INC | 41 | Q3 2023 | 7.8% |
| LILY ELI & CO | 41 | Q3 2023 | 6.9% |
| PFIZER INC | 41 | Q3 2023 | 2.9% |
| ATTUNITY LTD | 41 | Q3 2023 | 3.6% |
| EXPEDITORS INTL WASH INC | 41 | Q3 2023 | 2.3% |
| CVS HEALTH CORP | 41 | Q3 2023 | 1.6% |
| DONALDSON INC | 41 | Q3 2023 | 1.3% |
| VERIZON COMMUNICATIONS INC | 41 | Q3 2023 | 1.0% |
| US BANCORP DEL | 41 | Q3 2023 | 0.8% |
| BAXTER INTL INC | 40 | Q3 2023 | 14.1% |
View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BIOLASE, INC | May 15, 2023 | 689,196 | 2.1% |
| FlexShopper, Inc. | February 09, 2023 | 1,281,460 | 5.9% |
| Avinger Inc | February 14, 2020 | 891,761 | 5.2% |
| Black Ridge Oil & Gas, Inc. | February 15, 2019 | 30,021,032 | 6.3% |
| CANCER GENETICS, INC | February 15, 2019 | 1,135,250 | 4.0% |
| TearLab Corp | February 15, 2019 | 1,666,294 | 13.1% |
| Xtant Medical Holdings, Inc. | February 15, 2019 | 684,408 | 3.6% |
| TearLab Corp | January 26, 2018 | 4,300,655 | 40.1% |
| BIO KEY INTERNATIONAL INC | February 09, 2017 | 274,900 | 4.4% |
| EnteroMedics Inc | February 09, 2017 | 1,455 | 0.0% |
View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-09 |
| 13F-HR | 2024-01-22 |
| 13F-HR | 2023-11-02 |
| 13F-HR | 2023-07-21 |
| SC 13G/A | 2023-05-15 |
| 13F-HR | 2023-05-09 |
| SC 13G/A | 2023-02-09 |
| SC 13G | 2023-02-09 |
| 13F-HR | 2023-01-26 |
| 13F-HR | 2022-10-24 |
View PERKINS CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.